Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients.

Autor: Baudemont G; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France., Tardivon C; Département d'Epidémiologie Biostatistique et Recherche Clinique, AP-HP.Nord, Hôpital Bichat, Paris, France.; Centre d'Investigations Cliniques-Epidémiologie Clinique 1425, INSERM, Hôpital Bichat, Paris, France., Monneret G; Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hôpital, Lyon, France.; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Lyon, France., Cour M; Medical intensive Care Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Rimmelé T; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Lyon, France.; Anesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Garnier L; Immunology Laboratory, Hospices Civils de Lyon, Lyon-Sud University Hospital, Pierre Bénite, France., Yonis H; Medical intensive Care Department, Hospices Civils de Lyon, Croix-Rousse University Hospital, Lyon, France., Richard JC; Medical intensive Care Department, Hospices Civils de Lyon, Croix-Rousse University Hospital, Lyon, France., Coudereau R; Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hôpital, Lyon, France.; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Lyon, France., Gossez M; Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hôpital, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France., Wallet F; Intensive Care Department, Hospices Civils de Lyon, Lyon-Sud University Hospital, Pierre-Bénite, France., Delignette MC; Anesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Croix-Rousse University Hospital, Lyon, France., Dailler F; Neurological Anesthesiology and Intensive Care Department, Hospices Civils de Lyon, Pierre Wertheimer Hospital, Lyon, France., Buisson M; Centre d'Investigation Clinique de Lyon (CIC 1407 Inserm), Hospices Civils de Lyon, Lyon, France., Lukaszewicz AC; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Lyon, France.; Anesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Argaud L; Medical intensive Care Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Laouenan C; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France.; Département d'Epidémiologie Biostatistique et Recherche Clinique, AP-HP.Nord, Hôpital Bichat, Paris, France., Bertrand J; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France., Venet F; Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hôpital, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France.

Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jul; Vol. 13 (7), pp. 1130-1143. Date of Electronic Publication: 2024 Jun 05.

Persistent NLRP3 inflammasome activation is associated with delayed immunosuppression in septic patients.

Autor: Coudereau R; Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Place d'Arsonval, 69437 Lyon, France.; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France., Bodinier M; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France., Lukaszewicz AC; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France.; Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Place d'Arsonval, 69437 Lyon, France., Py BF; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Argaud L; Hospices Civils de Lyon, Edouard Herriot Hospital, Medical Intensive Care Department, Place d'Arsonval, 69437 Lyon, France., Cour M; Hospices Civils de Lyon, Edouard Herriot Hospital, Medical Intensive Care Department, Place d'Arsonval, 69437 Lyon, France., Bidar F; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France.; Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Place d'Arsonval, 69437 Lyon, France., Cerrato E; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France., Garnier L; Hospices Civils de Lyon, CH Lyon-Sud, Immunology Laboratory, 69310 Pierre Bénite, France., Gossez M; Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Place d'Arsonval, 69437 Lyon, France.; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Venet F; Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Place d'Arsonval, 69437 Lyon, France.; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Monneret G; Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Place d'Arsonval, 69437 Lyon, France.; EA 7426 'Pathophysiology of Injury-Induced Immunosuppression' (Université Claude Bernard Lyon 1-Hospices Civils de Lyon-bioMérieux), Joint Research Unit HCL-bioMérieux, Edouard Herriot Hospital, Place d'Arsonval, 69437 Lyon, France.

Publikováno v: Journal of leukocyte biology [J Leukoc Biol] 2024 Mar 29; Vol. 115 (4), pp. 706-713.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

Autor: Bidar, F., Hamada, S., Gossez, M., Coudereau, R., Lopez, J., Cazalis, M. A., Tardiveau, C., Brengel-Pesce, K., Mommert, M., Buisson, M., Conti, F., Rimmele, T., Lukaszewicz, A. C., Argaud, L., Cour, M., Monneret, G., Venet, F.

Publikováno v: Annals of Intensive Care
Annals of Intensive Care, 2022, 12 (1), pp.21. ⟨10.1186/s13613-022-00982-1⟩

Erratum inCorrection to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis MA, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0629270642076ecc0c8da161965cedd1
https://www.hal.inserm.fr/inserm-03754179

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Autor: Bidar F; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France.; Anesthesia and Critical Care Medicine Department, Edouard Herriot Hospital, Hospices Civils de Lyon, 69437, Lyon, France.; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France., Hamada S; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France., Gossez M; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude, Bernard-Lyon 1, Lyon, France., Coudereau R; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France.; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France., Lopez J; Biochemistry and Molecular Biology Laboratory, Lyon-Sud University Hospital-Hospices Civils de Lyon, Chemin du Grand Revoyet, Pierre-Benite, France., Cazalis MA; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France., Tardiveau C; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France., Brengel-Pesce K; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France., Mommert M; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France., Buisson M; Centre d'Investigation Clinique de Lyon (CIC 1407 Inserm), Hospices Civils de Lyon, 69677, Lyon, France., Conti F; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France., Rimmelé T; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France.; Anesthesia and Critical Care Medicine Department, Edouard Herriot Hospital, Hospices Civils de Lyon, 69437, Lyon, France., Lukaszewicz AC; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France.; Anesthesia and Critical Care Medicine Department, Edouard Herriot Hospital, Hospices Civils de Lyon, 69437, Lyon, France., Argaud L; Medical Intensive Care Department, Hospices Civils de Lyon, Edouard Herriot Hospital, 69437, Lyon, France., Cour M; Medical Intensive Care Department, Hospices Civils de Lyon, Edouard Herriot Hospital, 69437, Lyon, France., Monneret G; Joint Research Unit HCL-bioMérieux, EA 7426 'Pathophysiology of Injury-Induced Immunosuppression', Université Claude Bernard Lyon, 1-Hospices Civils de Lyon-bioMérieux, 69003, Lyon, France.; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France., Venet F; Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d'Arsonval, 69437, Lyon Cedex 03, France. fabienne.venet@chu-lyon.fr.; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude, Bernard-Lyon 1, Lyon, France. fabienne.venet@chu-lyon.fr.

Publikováno v: Annals of intensive care [Ann Intensive Care] 2022 Mar 05; Vol. 12 (1), pp. 21. Date of Electronic Publication: 2022 Mar 05.

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio.

Autor: Riff A; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France.; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils of Lyon, Immunology Laboratory, Edouard Herriot Hospital, Lyon, France., Haem Rahimi M; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Delignette MC; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Anaesthesiology and Critical Care Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France., Gossez M; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils of Lyon, Immunology Laboratory, Edouard Herriot Hospital, Lyon, France., Coudereau R; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils of Lyon, Immunology Laboratory, Edouard Herriot Hospital, Lyon, France., Pantel S; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France., Antonini T; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France.; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Villeret F; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France.; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Zoulim F; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France.; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Mabrut JY; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Department of Digestive Surgery and Liver Transplantation, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France., Dumortier J; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hepato-Gastroenterology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Edouard Herriot Hospital, Lyon, France., Venet F; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils of Lyon, Immunology Laboratory, Edouard Herriot Hospital, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France., Lebossé F; Hepatology Department, Hospices Civils of Lyon, Lyon Hepatology Institute, Croix-Rousse Hospital, Lyon, France.; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France., Monneret G; Medical School, University of Lyon, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils of Lyon, Immunology Laboratory, Edouard Herriot Hospital, Lyon, France.

Publikováno v: Frontiers in physiology [Front Physiol] 2023 Mar 30; Vol. 14, pp. 1095723. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023).